CSPG4P10

Across TCGA pan-cancer cohorts, CSPG4P10 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of CSPG4P10’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where CSPG4P10 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CSPG4P10 is over-expressed in tumor, although a few such as THCA and ESCA show the opposite, repressed pattern.

LIHC, COAD, and KIRC are the cancer types where CSPG4P10 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CSPG4P10 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	II,III,IV	+0.352	<.001	9	view →
COAD	All	All	+0.347	.001	5	view →
KIRC	All	All	+0.152	<.001	5	view →
READ	Female	All	+0.727	.025	4	view →
KIRP	All	IV	+0.557	.010	4	view →
KICH	All	II,III,IV	+0.404	.002	4	view →
THCA	All	All	−0.196	.003	4	view →
CHOL	Female	All	+1.543	<.001	3	view →
ESCA	Female	All	−1.140	.030	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

CSPG4P10–LIHC

Open the LIHC breakdown →